Evidence map›Paper›PMID 42558731›Full record

ArticleFrontiers in immunology2026

T cell antigenic recognition sequencing (TAR-seq) enables precise characterization of vaccine-elicited cellular immunity ex vivo and

Morgan Chaunzwa, G W McElfresh, David Morrow, Gregory J Boggy, Maanasa Kaza, Sebastian Benjamin, Shana Feltham, Sohita Ojha, Gwendolyn M Swarbrick, Katherine H Rott and 12 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Morgan ChaunzwaOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
G W McElfreshOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
David MorrowVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Gregory J BoggyOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
Maanasa KazaOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
Sebastian BenjaminOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
Shana FelthamVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Sohita OjhaVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Gwendolyn M SwarbrickDivision of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States.
Katherine H RottDivision of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States.
Roxanne M GilbrideVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Caralyn S LabriolaOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
Michael K AxthelmOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
Vineet JoagCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, United States.
Dylan KainUniversity Health Network, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Nelita Du PlessisSouth African Medical Research Council Centre for Tuberculosis Research; Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Gerhard WalzlSouth African Medical Research Council Centre for Tuberculosis Research; Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Deborah A LewinsohnDivision of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health and Sciences University, Portland, OR, United States.
David M LewinsohnDivision of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health and Sciences University, Portland, OR, United States.
Scott G HansenOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
Louis J PickerOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.
Benjamin N BimberOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States.

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH75N93019C00070 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI URDAHL, KEVIN · 2019 to 2025
$86.6M
Project 2: Systems biology analyses of RHCMV/SIV and IL-15 mechanisms of immune programmingP01AI177688 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale · 2023 to 2026
$8.1M
High Performance Computing and Machine Learning Infrastructure for Oregon Life SciencesS10OD034224 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLROTT, KYLE · 2023 to 2023
$2.0M
Bill & Melinda Gates Foundation INV-002377NIAID NIH HHS P01 AI177688NIH HHS 75N93019C00070NIH HHS P51 OD011092NIH HHS S10 OD034224
6 · The paper itself

Abstract

Introduction: The functional responses of antigen (Ag) specific T cells are complex, clonotype-specific, context-dependent, and incompletely captured by dominant analytic approaches. Here we present T Cell Antigenic Recognition Sequencing (TAR-seq), a two-part process that uses single-cell RNA + T cell receptor sequencing (scRNA/TCR-seq) to provide a precise and comprehensive characterization of the differentiation state and functional response of T cells specific to a given antigen, Methods: Many approaches use stimulation and activation-induced markers to identify Ag-specific T cells. We extend this by adding an scRNA/TCR-seq readout to identify the responding TCRs for each subject. We performed rigorous validation using tetramer-sorted T cells and developed a reusable probabilistic model to differentiate TCR-stimulated cells from bystander activation. These TCRs provide molecular barcodes to identify Ag-specific cells from unsorted scRNA/TCR-seq data, irrespective of stimulation, enabling a comprehensive view of their activity. Results: We applied this method to a cohort of SIV-vaccinated rhesus macaques (RMs). We performed SIV-infected cell recognition assays to identify the SIV-specific TCRs for each RM. We used these TCRs to subset SIV-specific cells and perform precise contrasts. Despite identical vaccination, we identified clone- and subject-level variability in their cytotoxic differentiation and cytokine production after incubation with SIV-infected targets. Per clonotype, the percentage of cells that responded after antigen exposure varied widely. Finally, we used TCRs as barcodes to precisely map the Discussion: Together, our data validate a powerful method to comprehensively understand T cell activity, with relevance to infectious disease, cancer, and autoimmunity, across species.

Indexed as

Immunity, CellularReceptors, Antigen, T-CellSimian Immunodeficiency VirusT-LymphocytesVaccinesAnimalsHumansLymphocyte ActivationMacaca mulattaSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisReceptors, Antigen, T-CellVaccinesantigen-specific activationsingle-cell RNA-seqT cell activationT cell receptor (TCR)T cells

Identifiers

PMID42558731
PMCPMC13438159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.